STROBE-AMS: Recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship

BMJ Open

Volumn 6, Issue 2, 2016, Pages

  Tacconelli, Evelina ^a,b   Cataldo, Maria A ^c   Paul, M ^d   Leibovici, L ^e   Kluytmans, Jan ^f   Schröder, Wiebke ^a,b   Foschi, Federico ^a,b   Angelis, Giulia De ^c   Waure, Chiara De ^g   Cadeddu, Chiara ^g   Mutters, Nico T ^h   Gastmeier, Petra ⁱ   Cookson, Barry ^j  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b German Center for Research in Infectious Disease (DZIF)   (Germany)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d Rambam Health Care Campus ^*  (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁱ HUMBOLDT UNIVERSITY   (Germany)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; DELPHI STUDY; HUMAN; MEDLINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; SYSTEMATIC REVIEW; ACINETOBACTER INFECTION; CHECKLIST; CLINICAL PRACTICE; EPIDEMIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION; TOTAL QUALITY MANAGEMENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; CHECKLIST; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGIC METHODS; EPIDEMIOLOGIC STUDIES; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE PATTERNS, PHYSICIANS'; QUALITY IMPROVEMENT; STAPHYLOCOCCAL INFECTIONS;

EID: 84960389590     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010134     Document Type: Article

References (21)

1. Davis S. Infections and the rise of antimicrobial resistance. Vol 2. Chief medical officer annual report; 2011.
2. Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008;61:26.38.
3. Cobos-Trigueros N, Sole M, Castro P, et al. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care 2015;19:218.
4. Tinelli M, Cataldo MA, Mantengoli E, et al. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother 2012;67:2982.7.
5. Aldeyab MA, Monnet DL, Lopez-Lozano JM, et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008;62:593.600.
6. Martin-Loeches I, Diaz E, Valles J. Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care 2014;20:516.24.
7. Dik JW, Vemer P, Friedrich AW, et al. Financial evaluations of antibiotic stewardship programs.a systematic review. Front Microbiol 2015;6:317.
8. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159.77.
9. Tamma PD, Holmes A, Ashley ED. Antimicrobial stewardship: another focus for patient safety? Curr Opin Infect Dis 2014;27:348.55.
10. Tacconelli E, Cataldo MA. Identifying risk factors for infections: the role of meta-analyses. Infect Dis Clin North Am 2009;23:211.24.
11. Sharp SJ, Poulaliou M, Thompson SG, et al. A review of published analyses of case-cohort studies and recommendations for future reporting. PLoS ONE 2014;9:e101176.
12. Harris AD, McGregor JC. The importance of case-mix adjustment for infection rates and the need for more research. Infect Control Hosp Epidemiol 2008;29:693.4.
13. MacAdam H, Zaoutis TE, Gasink LB, et al. Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use. Int J Antimicrob Agents 2006;28:325.32.
14. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.
15. Field N, Cohen T, Struelens MJ, et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis 2014;14:341.52.
16. Curcio D. Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge? Curr Clin Pharmacol 2014;9:27.38.
17. Williams PL, Webb C. The Delphi technique: a methodological discussion. J Adv Nurs 1994;19:180.6.
18. Savard P, Perl TM. A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings. Curr Opin Infect Dis 2012;25:371.7.
19. World Health Organisation. The evolving threat of antimicrobial resistance.options for actions. WHO Library Cataloguing in Publication Data, 2012.
20. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663.94.
21. Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Int J Surg 2010;8:336.41.